ONCS BRAS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.45 BRL | -9.37% |
|
+24.58% | -42.69% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,254 | 2,889 | 6,603 | 3,787 | - | - |
| Enterprise Value (EV) 1 | 5,364 | 6,100 | 10,607 | 7,700 | 7,482 | 7,093 |
| P/E ratio | -98.7 x | 69.3 x | - | 15.1 x | 8.71 x | 8.28 x |
| Yield | - | - | - | 2.82% | 1.95% | - |
| Capitalization / Revenue | 1.94 x | 0.71 x | 1.2 x | 0.58 x | 0.5 x | 0.45 x |
| EV / Revenue | 1.99 x | 1.49 x | 1.93 x | 1.18 x | 0.99 x | 0.84 x |
| EV / EBITDA | 11.1 x | 7.96 x | 9.35 x | 5.96 x | 4.82 x | 4.24 x |
| EV / FCF | -25.4 x | -10.6 x | - | -48.1 x | 8.93 x | 6.57 x |
| FCF Yield | -3.94% | -9.44% | - | -2.08% | 11.2% | 15.2% |
| Price to Book | 2.88 x | 1.36 x | - | 1.47 x | 1.39 x | - |
| Nbr of stocks (in thousands) | 4,66,986 | 4,79,114 | 5,07,910 | 5,08,285 | - | - |
| Reference price 2 | 11.25 | 6.030 | 13.00 | 7.450 | 7.450 | 7.450 |
| Announcement Date | 29/03/22 | 28/03/23 | 27/03/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,035 | 2,702 | 4,088 | 5,489 | 6,548 | 7,575 | 8,433 |
| EBITDA 1 | - | 481.1 | 766.2 | 1,134 | 1,293 | 1,552 | 1,674 |
| EBIT 1 | - | 177.2 | 470.6 | 758 | 1,019 | 1,224 | 1,421 |
| Operating Margin | - | 6.56% | 11.51% | 13.81% | 15.56% | 16.15% | 16.85% |
| Earnings before Tax (EBT) 1 | - | 62.3 | 121.5 | 302.5 | 336.5 | 840.4 | 851 |
| Net income 1 | -38.54 | -22.4 | 46.26 | 312.6 | 326 | 495.4 | 562 |
| Net margin | -1.89% | -0.83% | 1.13% | 5.7% | 4.98% | 6.54% | 6.66% |
| EPS 2 | - | -0.1140 | 0.0870 | - | 0.4933 | 0.8550 | 0.9000 |
| Free Cash Flow 1 | - | -211.2 | -575.8 | - | -160 | 838 | 1,080 |
| FCF margin | - | -7.82% | -14.08% | - | -2.44% | 11.06% | 12.81% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 54.01% | 64.51% |
| FCF Conversion (Net income) | - | - | - | - | - | 169.16% | 192.17% |
| Dividend per Share 2 | - | - | - | - | 0.2100 | 0.1450 | - |
| Announcement Date | 26/03/21 | 29/03/22 | 28/03/23 | 27/03/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 679.4 | 767.9 | 808 | 899.9 | 1,164 | 1,216 | 1,294 | 1,360 | 1,402 | 1,434 | 1,459 | 1,613 | 1,682 | 1,720 |
| EBITDA 1 | 117.6 | 140 | 141.3 | 158.9 | 213 | 253.1 | 291.7 | 285.4 | 285.4 | 271.7 | 254.4 | 337.1 | 329.3 | 330.5 |
| EBIT 1 | 196.3 | 73.1 | - | 76 | 131.1 | 190.9 | - | 187.6 | 184 | 177.7 | 166.8 | 258.8 | 250.7 | 245.6 |
| Operating Margin | 28.89% | 9.52% | - | 8.45% | 11.26% | 15.69% | - | 13.8% | 13.13% | 12.39% | 11.43% | 16.04% | 14.9% | 14.27% |
| Earnings before Tax (EBT) | - | - | - | - | 34.9 | 65.1 | - | 70.49 | - | 119.1 | - | - | - | - |
| Net income 1 | - | - | - | - | 30.8 | 71.11 | - | 21.01 | 105 | 87 | 19.6 | - | - | - |
| Net margin | - | - | - | - | 2.65% | 5.85% | - | 1.55% | 7.49% | 6.07% | 1.34% | - | - | - |
| EPS 2 | 0.3614 | 0.0374 | -0.0484 | -0.0700 | 0.0649 | 0.1389 | 0.0400 | 0.0398 | - | - | 0.0349 | 0.0768 | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 16/11/21 | 29/03/22 | 16/05/22 | 15/08/22 | 10/11/22 | 28/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 27/03/24 | 13/05/24 | - | - | - |
1BRL in Million2BRL
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 110 | 3,211 | 4,004 | 3,913 | 3,695 | 3,307 |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 0.2289 x | 4.191 x | 3.531 x | 3.026 x | 2.382 x | 1.975 x |
| Free Cash Flow 1 | - | -211 | -576 | - | -160 | 838 | 1,080 |
| ROE (net income / shareholders' equity) | - | -0.99% | 2.33% | 14.1% | 8.03% | 14.2% | 16.6% |
| ROA (Net income/ Total Assets) | - | -0.48% | 0.65% | 3.59% | - | - | - |
| Assets 1 | - | 4,713 | 7,126 | 8,700 | - | - | - |
| Book Value Per Share 2 | - | 3.900 | 4.430 | - | 5.070 | 5.350 | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | - | 202 | 304 | - | 608 | 312 | 364 |
| Capex / Sales | - | 7.47% | 7.44% | - | 9.29% | 4.12% | 4.32% |
| Announcement Date | 26/03/21 | 29/03/22 | 28/03/23 | 27/03/24 | - | - | - |
1BRL in Million2BRL
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.45
BRL
Average target price
14.06
BRL
Spread / Average Target
+88.76%
EPS Revisions
- Stock Market
- Equities
- ONCO3 Stock
- Financials ONCS BRAS
